In post-treatment tumors, genes such as FOS, JUNB, COL1A2, and DUSP1 have shown to favor cancer proliferation and invasion (46, 53) and were predominantly expressed compared with pre-treatment tumors. The gene discussed is FOS; the disease is cancer.